Ninety percent of HIV-1-infected people worldwide harbour non-subtype B variants of HIV-1.
Yet knowledge of resistance mutations in non-B HIV-1 and their clinical relevance is limited …

Objective The objective of this review was to assess the burden of HIV drug resistance
mutations (DRM) in Indian adults exposed to first-line antiretroviral therapy (ART) as per …

This study was conducted to examine the relationship between adherence, viral load (VL)
and resistance among outpatients receiving highly active antiretroviral therapy (HAART) in …

We investigated whether reverse transcriptase (RT) inhibitors (RTI) can be combined to
inhibit human immunodeficiency virus type 1 (HIV-1) infection of colorectal tissue ex vivo as …

Background Emergence of HIV-1 drug resistance is at times an inevitable and anticipated
consequence of antiretroviral therapy (ART) failure. We examined drug resistance patterns …

Abstract In 2010, 3.5 million people were living with HIV in the World Health Organization
(WHO) Southeast Asia Region (SEAR), giving this region the greatest burden of HIV after …

Human immunodeficiency virus drug resistance (HIVDR) in cohorts of patients initiating
antiretroviral therapy (ART) at clinics in Chennai and Mumbai, India, was assessed following …

Background Antiretroviral therapy (ART) effectiveness is compromised by the emergence of
HIV drug resistance mutations (DRM) and can lead to the failure of ART. Apart from intrinsic …

The year 1986 saw first case of HIV infection as well as first report of AIDS case in India.
Since then the epidemic has spread throughout the country. In the recent years there is …

Background. A cross-sectional study among individuals receiving second-line antiretroviral
treatment was conducted to report on the level of detectable viremia and the types of drug …